| SpectraBase Spectrum ID |
GU3LEybT7vk |
| Name |
1-(3-Bromobenzyl)-4-(2-dimethylaminoethyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
325.115360785 u |
| Formula |
C15H24BrN3 |
| InChI |
InChI=1S/C15H24BrN3/c1-17(2)6-7-18-8-10-19(11-9-18)13-14-4-3-5-15(16)12-14/h3-5,12H,6-11,13H2,1-2H3 |
| InChIKey |
YIBUQSOSATUWOM-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
326.282 g/mol |
| Nominal Mass |
325 u |
| Quality |
945 |
| Retention Index |
2166 |
| SMILES |
C(N1CCN(CC1)CCN(C)C)C=1C=C(C=CC1)Br |
| SPLASH |
splash10-06di-9350000000-6bb53bbe6fbd7ea15b37 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(3-bromobenzyl)-4-(2-dimethylaminoethyl)
2-(4-(3-bromobenzyl)piperazin-1-yl)-N,N-dimethylethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011199 |
